Papers - MATSUSHITA, Tadashi
-
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results
Shapiro Amy D., Angchaisuksiri Pantep, Astermark Jan, Benson Gary, Castaman Giancarlo, Chowdary Pratima, Eichler Hermann, Jimenez-Yuste Victor, Kavakli Kaan, Matsushita Tadashi, Poulsen Lone Hvitfeldt, Wheeler Allison P., Young Guy, Zupancic-Salek Silva, Oldenburg Johannes
BLOOD Vol. 134 ( 22 ) page： 1973 - 1982 2019.11
-
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Shapiro Amy, Castaman Giancarlo, Cepo Katarina, Poulsen Lone Hvitfeldt, Hollensen Christian, Matsushita Tadashi, Young Guy, Zupancic-Salek Silva, Jimenez-Yuste Victor
BLOOD Vol. 134 2019.11
-
Phase I Study of Cord Blood Transplantation with Intra-Bone Marrow Injection of Mesenchymal Stem Cells
Goto Tatsunori, Murata Makoto, Nishida Tetsuya, Terakura Seitaro, Kamoshita Sonoko, Ishikawa Yuichi, Ushijima Yoko, Adachi Yoshiya, Kato Katsuyoshi, Hirakawa Akihiro, Nishiwaki Satoshi, Nishio Nobuhiro, Takahashi Yoshiyuki, Kodera Yoshihisa, Matsushita Tadashi, Kiyoi Hitoshi
BLOOD Vol. 134 2019.11
-
Real-World Effectiveness and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) in Previously Treated Patients with Hemophilia A (HEM-POWR): Online Patient Portal and LIFE-ACTIVE Sub-Study
Oldenburg Johannes, Roman Maria Teresa Alvarez, Castaman Giancarlo, Janbain Maissaa, Matsushita Tadashi, Meijer Karina, Friedl Sabine, Sanabria Martin, Reding Mark
BLOOD Vol. 134 2019.11
-
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP
Davis Joanna, Yan Songkai, Matsushita Tadashi, Alberio Lorenzo, Bassett Paul, Santagostino Elena
JOURNAL OF MEDICAL ECONOMICS Vol. 22 ( 10 ) page： 1014 - 1021 2019.10
-
Performance evaluation of Revohem((TM)) FVIII chromogenic and Revohem((TM)) FIX chromogenic in the CS-5100 autoanalyser
Suzuki Atsuo, Suzuki Nobuaki, Kanematsu Takeshi, Shinohara Sho, Arai Nobuo, Kikuchi Ryosuke, Matsushita Tadashi
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Vol. 41 ( 5 ) page： 664 - 670 2019.10
-
Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with Inhibitors.
Okamoto S, Suzuki N, Suzuki A, Suzuki S, Tamura S, Suzuki M, Takahashi N, Kojima T, Kanematsu T, Kojima T, Kiyoi H, Ishiguro N, Matsushita T
TH open : companion journal to thrombosis and haemostasis Vol. 3 ( 4 ) page： e364 - e366 2019.10
-
LIFE-ACTIVE: OBSERVATIONAL STUDY EVALUATING THE PHYSICAL ACTIVITY IN A SUBSET OF DAM OCT OCOG ALFA PEGOL TREATED HEMOPHILIA A PATIENTS WHO ARE ENROLLED IN THE HEM- POWR STUDY
Musi E., Sanabria M., Alvarez Roman M. T., Castaman G., Janbain M., Matsushita T., Meijer K., Oldenburg J., Friedl S., Reding M.
HAEMATOLOGICA Vol. 104 page： 16 - 16 2019.9
-
Management of Neonatal Alloimmune Thrombocytopenia in Type 1 CD36 Deficiency Pregnant Women
Matsushita Tadashi, Sanda Naomi, Watanabe Tomomi, Endo Hiroko, Kato Chiaki
TRANSFUSION Vol. 59 page： 130A - 130A 2019.9
-
Apolipoprotein E binds to and reduces serum levels of DNA-mimicking, pyrrolated proteins
Hirose Sayumi, Hioki Yusuke, Miyashita Hiroaki, Hirade Naoya, Yoshitake Jun, Shibata Takahiro, Kikuchi Ryosuke, Matsushita Tadashi, Chikazawa Miho, Itakura Masanori, Zhang Mimin, Nagata Koji, Uchida Koji
JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 294 ( 28 ) page： 11035 - 11045 2019.7
-
Apparent synonymous mutation F9 c.87A > G causes secretion failure by in-frame mutation with aberrant splicing
Odaira Koya, Tamura Shogo, Suzuki Nobuaki, Kakihara Misaki, Hattori Yuna, Tokoro Mahiru, Suzuki Sachiko, Takagi Akira, Katsumi Akira, Hayakawa Fumihiko, Okamoto Shuichi, Suzuki Atsuo, Kanematsu Takeshi, Matsushita Tadashi, Kojima Tetsuhito
THROMBOSIS RESEARCH Vol. 179 page： 95 - 103 2019.7
-
Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia
Nagao Azusa, Suzuki Nobuaki, Takedani Hideyuki, Yamasaki Naoya, Chikasawa Yushi, Sawada Akihiro, Kanematsu Takeshi, Nojima Masanori, Higasa Satoshi, Amano Kagehiro, Fukutake Katsuyuki, Fujii Teruhisa, Matsushita Tadashi, Suzuki Takashi
HAEMOPHILIA Vol. 25 ( 4 ) page： E223 - E230 2019.7
-
Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B
Fukutake Katsuyuki, Taki Masashi, Matsushita Tadashi, Sakai Michio, Takata Ami, Yamaguchi Hiromi, Karumori Toshiyuki
HAEMOPHILIA Vol. 25 ( 4 ) page： E247 - E256 2019.7
-
Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency
Tamura Shogo, Hashimoto Erika, Suzuki Nobuaki, Kakihara Misaki, Odaira Koya, Hattori Yuna, Tokoro Mahiru, Suzuki Sachiko, Takagi Akira, Katsumi Akira, Hayakawa Fumihiko, Suzuki Atsuo, Okamoto Shuichi, Kanematsu Takeshi, Matsushita Tadashi, Kojima Tetsuhito
THROMBOSIS RESEARCH Vol. 178 page： 159 - 170 2019.6
-
Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis
Bannow Bethany Samuelson, Recht Michael, Negrier Claude, Hermans Cedric, Berntorp Erik, Eichler Hermann, Mancuso Maria Elisa, Klamroth Robert, O'Hara Jamie, Santagostino Elena, Matsushita Tadashi, Kessler Craig
BLOOD REVIEWS Vol. 35 page： 43 - 50 2019.5
-
Inhibitor development, safety and efficacy of Advate((R)) among previously treated patients with hemophilia A in a postmarketing surveillance in Japan
Fukutake Katsuyuki, Taki Masashi, Matsushita Tadashi, Nogami Keiji, Shima Midori, Yoshioka Akira, Takamatsu Junki, Uchikawa Haruhiko, Takagi Hiroshi, Arai Morio, Engl Werner, Shirahata Akira
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 109 ( 3 ) page： 336 - 345 2019.3
-
Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders
Suzuki Atsuo, Suzuki Nobuaki, Kanematsu Takeshi, Shinohara Sho, Arai Nobuo, Kikuchi Ryosuke, Matsushita Tadashi
THROMBOSIS RESEARCH Vol. 174 page： 98 - 103 2019.2
-
Inhibitor development, safety, and efficacy of Advate (R) in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan (vol 109, pg 70, 2019)
Taki Masashi, Fukutake Katsuyuki, Matsushita Tadashi, Nogami Keiji, Shima Midori, Yoshioka Akira, Takamatsu Junki, Arai Morio, Takagi Hiroshi, Uchikawa Haruhiko, Engl Werner, Shirahata Akira
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 109 ( 2 ) page： 241 - 241 2019.2
-
Inhibitor development, safety, and efficacy of Advate((R)) in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
Taki Masashi, Fukutake Katsuyuki, Matsushita Tadashi, Nogami Keiji, Shima Midori, Yoshioka Akira, Takamatsu Junki, Arai Morio, Takagi Hiroshi, Uchikawa Haruhiko, Engl Werner, Shirahata Akira
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 109 ( 1 ) page： 70 - 78 2019.1
-
B-YOND Final Results Confirm Established Safety, Sustained Efficacy, and Extended Dosing Interval for Up to 4 Years of Treatment With rFIXFc in Previously Treated Subjects With Severe Hemophilia B
Ragni Margaret, Kulkarni Roshni, Pasi K. John, Fischer Kathelijn, Mahlangu Johnny, Shapiro Amy, Nolan Beatrice, Oldenburg Johannes, Matsushita Tadashi, Willemze Annemieke, Yuan Huixing, Rudin Dan
BLOOD Vol. 132 2018.11